Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4

被引:29
作者
Jones, JB
Kern, SE
机构
[1] Johns Hopkins Univ, Predoctoral Program Human Genet, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
关键词
D O I
10.1093/nar/28.12.2363
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor Smad4 binds DNA in response to a TGF-beta ligand-initiated intracellular signaling cascade. SMAD4 is deleted or mutated during tumorigenesis in many human tumors. Some of these mutations occur in the N-terminal portion of the protein, the Mad homology 1 (MH1) region, which exhibits sequence-specific DNA-binding. We used alanine scanning mutagenesis and natural mutations to map the subregion of the MH1 domain necessary for that function. We created 20 individual mutations in the MH1 region of human Smad4 and assayed their effect on DNA-binding in vitro. Mutation of residues in the less conserved N- and C-terminal areas of the MH1 region had no effect on DNA-binding. However, mutations in the domain from L43 to R135 caused a dramatic reduction of the ability of Smad4 to bind DNA. Previous work demonstrated a beta-hairpin protein motif within this region to be responsible for DNA-binding, but suggested that the tumorigenic mutations occurring outside this motif may target a separate function of the MH1 domain. Our results demonstrate that the MH1 domain as a whole is very sensitive to changes in overall structure, and that tumorigenic mutations within the region of L43-R135 indeed would target DNA-binding.
引用
收藏
页码:2363 / 2368
页数:6
相关论文
共 17 条
[1]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[2]  
Dai JL, 1998, CANCER RES, V58, P4592
[3]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[4]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[5]   Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 [J].
Hata, A ;
Lo, RS ;
Wotton, D ;
Lagna, G ;
Massague, J .
NATURE, 1997, 388 (6637) :82-87
[6]   TGF-beta signalling from cell membrane to nucleus through SMAD proteins [J].
Heldin, CH ;
Miyazono, K ;
tenDijke, P .
NATURE, 1997, 390 (6659) :465-471
[7]   Drosophila MAD binds to DNA and directly mediates activation of vestigial by decapentaplegic [J].
Kim, J ;
Johnson, K ;
Chen, HJ ;
Carroll, S ;
Laughon, A .
NATURE, 1997, 388 (6639) :304-308
[8]   Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers:: identification of seven novel somatic mutations in tumors from Japanese patients [J].
Koyama, M ;
Ito, M ;
Nagai, H ;
Emi, M ;
Moriyama, Y .
MUTATION RESEARCH-GENOMICS, 1999, 406 (2-4) :71-77
[9]   A human Mad protein acting as a BMP-regulated transcriptional activator [J].
Liu, F ;
Hata, A ;
Baker, JC ;
Doody, J ;
Carcamo, J ;
Harland, RM ;
Massague, J .
NATURE, 1996, 381 (6583) :620-623
[10]   Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas [J].
MacGrogan, D ;
Pegram, M ;
Slamon, D ;
Bookstein, R .
ONCOGENE, 1997, 15 (09) :1111-1114